Cabaletta Retained Earnings vs Deferred Long Term Liab Analysis
CABA Stock | USD 1.87 0.39 17.26% |
Cabaletta Bio financial indicator trend analysis is way more than just evaluating Cabaletta Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cabaletta Bio is a good investment. Please check the relationship between Cabaletta Bio Retained Earnings and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Retained Earnings vs Deferred Long Term Liab
Retained Earnings vs Deferred Long Term Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cabaletta Bio Retained Earnings account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between Cabaletta Bio's Retained Earnings and Deferred Long Term Liab is 0.76. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Cabaletta Bio, assuming nothing else is changed. The correlation between historical values of Cabaletta Bio's Retained Earnings and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Cabaletta Bio are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Retained Earnings i.e., Cabaletta Bio's Retained Earnings and Deferred Long Term Liab go up and down completely randomly.
Correlation Coefficient | 0.76 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Most indicators from Cabaletta Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.The current year's Issuance Of Capital Stock is expected to grow to about 194.5 M, whereas Selling General Administrative is forecasted to decline to about 10.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 46.3M | 54.1M | 74.7M | 78.4M | Research Development | 32.5M | 39.3M | 55.4M | 58.2M |
Cabaletta Bio fundamental ratios Correlations
Click cells to compare fundamentals
Cabaletta Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cabaletta Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 141.5M | 114.7M | 126.3M | 117.0M | 253.7M | 266.3M | |
Other Current Liab | 2.2M | 3.9M | 6.0M | 2.7M | 4.3M | 3.1M | |
Total Current Liabilities | 3.1M | 5.2M | 8.4M | 9.5M | 16.0M | 16.8M | |
Total Stockholder Equity | 138.3M | 109.5M | 118.0M | 104.5M | 236.2M | 248.0M | |
Net Tangible Assets | 138.3M | 109.5M | 116.6M | 104.5M | 120.2M | 84.0M | |
Net Debt | (136.2M) | (101.4M) | (122.2M) | (76.5M) | (188.2M) | (178.8M) | |
Retained Earnings | (33.0M) | (66.3M) | (112.6M) | (165.6M) | (233.2M) | (221.6M) | |
Accounts Payable | 920K | 1.2M | 2.3M | 2.5M | 4.5M | 4.8M | |
Cash | 136.2M | 101.4M | 122.2M | 81.6M | 193.2M | 104.9M | |
Non Current Assets Total | 916K | 1.2M | 1.8M | 8.1M | 9.2M | 9.6M | |
Non Currrent Assets Other | 101K | 299K | 357K | 565K | 1.7M | 1.8M | |
Cash And Short Term Investments | 136.2M | 108.7M | 122.2M | 106.5M | 241.2M | 253.3M | |
Common Stock Shares Outstanding | 24.0M | 23.1M | 25.7M | 29.3M | 40.9M | 28.3M | |
Liabilities And Stockholders Equity | 141.5M | 114.7M | 126.3M | 117.0M | 253.7M | 266.3M | |
Non Current Liabilities Total | 920K | 1.2M | 2.3M | 3.0M | 1.5M | 1.4M | |
Capital Surpluse | 1.8M | 171.3M | 175.8M | 270.1M | 310.6M | 326.2M | |
Other Stockholder Equity | 29.8M | 175.8M | 230.5M | 270.1M | 469.4M | 492.9M | |
Total Liab | 3.1M | 5.2M | 8.4M | 12.4M | 17.5M | 10.5M | |
Net Invested Capital | 138.3M | 109.5M | 118.0M | 104.5M | 236.2M | 248.0M | |
Total Current Assets | 140.6M | 113.5M | 124.5M | 108.8M | 244.5M | 256.7M | |
Net Working Capital | 137.4M | 108.4M | 116.2M | 99.3M | 228.5M | 239.9M | |
Other Assets | 101K | 299.0 | 357K | 565K | 1.0 | 0.95 | |
Other Current Assets | 4.3M | 1.9M | 2.3M | 2.3M | 3.2M | 2.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.